FR7058M - - Google Patents

Info

Publication number
FR7058M
FR7058M FR124050A FR124050A FR7058M FR 7058 M FR7058 M FR 7058M FR 124050 A FR124050 A FR 124050A FR 124050 A FR124050 A FR 124050A FR 7058 M FR7058 M FR 7058M
Authority
FR
France
Prior art keywords
ribonuclease
oct
compound
immunosuppressive
globulin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR124050A
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Application granted granted Critical
Publication of FR7058M publication Critical patent/FR7058M/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/643—Albumins, e.g. HSA, BSA, ovalbumin or a Keyhole Limpet Hemocyanin [KHL]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22—Ribonucleases RNAses, DNAses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FR124050A 1966-10-12 1967-10-11 Expired FR7058M (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB45695/66A GB1136039A (en) 1966-10-12 1966-10-12 Improvements relating to immunosuppressive agents

Publications (1)

Publication Number Publication Date
FR7058M true FR7058M (fr) 1969-06-23

Family

ID=10438194

Family Applications (2)

Application Number Title Priority Date Filing Date
FR1552939D Expired FR1552939A (fr) 1966-10-12 1967-10-11
FR124050A Expired FR7058M (fr) 1966-10-12 1967-10-11

Family Applications Before (1)

Application Number Title Priority Date Filing Date
FR1552939D Expired FR1552939A (fr) 1966-10-12 1967-10-11

Country Status (6)

Country Link
AT (1) AT275037B (fr)
BE (1) BE705035A (fr)
ES (1) ES345979A1 (fr)
FR (2) FR1552939A (fr)
GB (1) GB1136039A (fr)
NL (1) NL6713800A (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4043869A (en) 1972-07-13 1977-08-23 Koch-Light Laboratories, Ltd. Water insoluble biologically active material
ES2759252T3 (es) 2013-10-31 2020-05-08 Resolve Therapeutics Llc Fusiones y métodos terapéuticos de nucleasa-albúmina

Also Published As

Publication number Publication date
AT275037B (de) 1969-10-10
NL6713800A (fr) 1968-04-16
FR1552939A (fr) 1969-01-10
GB1136039A (en) 1968-12-11
ES345979A1 (es) 1968-12-01
BE705035A (fr) 1968-04-12

Similar Documents

Publication Publication Date Title
NL7714329A (nl) Werkwijze ter bereiding van 3-de-0-methylforti- micinen alsmede farmaceutische preparaten die deze verbindingen als actieve component bevatten.
NL7507268A (nl) Werkwijze ter bereiding van 1(alpha),24-dihydroxy-chole- calciferolen, alsmede derivaten en voorlopers daar- van , alsmede farmaceutische preparaten die deze ver- bindingen als actieve componenten bevatten.
NL7700379A (nl) Werkwijze ter bereiding van anthracyclinegly- cosiden, alsmede farmaceutische preparaten die deze verbindingen als actieve component bevatten.
FR1552939A (fr)
NL7708982A (nl) Werkwijze ter bereiding van dihydro-oxo-nicotine- zuren, alsmede farmaceutische preparaten die de- ze verbinding als actieve component bevatten.
NL7711414A (nl) Werkwijze ter bereiding van n-gesubstitueerde lactamen, alsmede farmaceutische preparaten die deze verbindingen als actieve component bevatten.
CA2139518A1 (fr) Regions antigeniques des complexes de particules liberes par les tumeurs et anticorps
NL7702180A (nl) Werkwijze ter bereiding van 9-gesubstitueerde- -8-azapurinen alsmede farmaceutische preparaten die deze verbindingen als actieve component bevatten.
GB1260963A (en) Substituted insulins
GB1179787A (en) Stabilised and Potentiated Therapeutic Enzyme Compositions
NL7714063A (nl) Werkwijze ter bereiding van imidazolinen alsmede pesticidepreparaten die deze verbindingen als actieve component bevatten.
NL172446C (nl) Werkwijze voor de bereiding van 4-aryl-1-(4.4-diarylbutyl)4-hydroxypiperidinen en werkwijze voor de bereiding van farmaceutische preparaten.
IE34609L (en) Therapeutic substituted thiazolidinedione
NL7513011A (nl) Werkwijze ter bereiding van 1,2,3,4-tetrahydroiso- chinolinen alsmede farmaceutische preparaten die deze verbindingen als actieve component bevatten.
NL7606457A (nl) Werkwijze ter bereiding van 7(beta)-acyloxycefalospo- rinen en 7(beta)-hydroxy-tussenprodukten alsmede farma- ceutische preparaten die de eerste verbindingen als actieve component omvatten.
NL7511662A (nl) Werkwijze ter bereiding van 1-gesubstitueerde deri- vaten van 6'n-methyl-3'-4'-dideoxykanamycine b, alsmede farmaceutische preparaten die deze verbin- dingen als actieve component bevatten.
NL7709466A (nl) Werkwijze ter bereiding van cefalosporinen, alsmede farmaceutische preparaten die deze verbindingen als actieve component bevatten.
NL7608319A (nl) Werkwijze ter bereiding van 1,2,3,4-tetrahydro- -isochinolinen, alsmede farmaceutische prepa- raten die deze verbindingen als actieve compo- nent bevatten.
GB1199951A (en) Modified Dextran and Derivatives Thereof
NL7708177A (nl) Werkwijze ter bereiding van cefemderivaten, als- mede farmaceutische preparaten die deze verbin- ding als actieve component bevatten.
GB1222294A (en) Oxazinobenzodiazepine derivatives
NL7705446A (nl) Werkwijze ter bereiding van fenethanolaminen met farmaceutische werking alsmede preparaten die deze verbindingen als actieve component bevatten.
CA769021A (en) 9.beta.,10.alpha.-STEROIDS, METHODS OF PRODUCING SAID COMPOUNDS AND METHODS OF PRODUCING PHARMACEUTIC PREPARATIONS CONTAINING SAID COMPOUNDS AS ACTIVE CONSTITUENTS AND SAID PREPARATIONS
GB1197605A (en) Therapeutic Composition
NL7416066A (nl) Trialkyl gesubstitueerde hydroxybenzylmalonaten en gestabiliseerde preparaten.

Legal Events

Date Code Title Description
ST Notification of lapse